James V. Caruso

2021

In 2021, James V. Caruso earned a total compensation of $2.2M as President and Chief Executive Officer at Cellectar Biosciences, a 112% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$156,750
Option Awards$1,472,000
Salary$522,500
Total$2,151,250

Caruso received $1.5M in option awards, accounting for 68% of the total pay in 2021.

Caruso also received $156.8K in non-equity incentive plan and $522.5K in salary.

Rankings

In 2021, James V. Caruso's compensation ranked 5,771st out of 12,415 executives tracked by ExecPay. In other words, Caruso earned more than 53.5% of executives.

ClassificationRankingPercentile
All
5,771
out of 12,415
54th
Division
Manufacturing
2,445
out of 5,501
56th
Major group
Chemicals And Allied Products
1,059
out of 2,374
55th
Industry group
Drugs
944
out of 2,095
55th
Industry
Pharmaceutical Preparations
677
out of 1,542
56th
Source: SEC filing on April 29, 2022.

Caruso's colleagues

We found three more compensation records of executives who worked with James V. Caruso at Cellectar Biosciences in 2021.

2021

Jarrod Longcor

Cellectar Biosciences

Chief Operating Officer

2021

Dov Elefant

Cellectar Biosciences

Chief Financial Officer

2021

John Friend

Cellectar Biosciences

Chief Medical Officer

News

In-depth

You may also like